A possible reason for this is that RET positive NSCLC is considered a “cold” tumor, similar to other types of oncogene-addicted NSCLCs, characterized by low PD-L1 expression and tumor mutational burden (TMB) [19]. This evidence concerns the gene CD274 and neoplasm.